Register Today!
  • Extractables & Leachables Europe
  • Extractables and Leachables USA
  • Extractables & Leachables China

Extractables and Leachables USA

June 28 - July 1, 2021
Arlington, VA

Save the date! Extractables and Leachables USA 2021 is coming to Arlington, VA, June 28 - July 1, 2021.



Extractables and Leachables USA 2021coming to Arlington, VA this June 28 - July 1, is focusing on Adapting and Thriving in the Face of Change: Navigating the Challenges of an Evolving Landscape and Preparing for the Future of E&L. 

2021 Featured Sessions Include: 

  • Global E&L Landscape and Market update: Updates on Regulations, ISO Standards, Etc.
  • Case Studies
  • E&L and COVID, Lessons Learned
  •  Manufacturing
Extractables & Leachables USA offers a unique opportunity for leading E&L experts and decision makers to discuss the latest updates on regulations, best practices, compliance, case studies, biocompatibility, BPOG, USP, advances in the sector, working group updates, and much more. Attendees network, build beneficial relationships, and hear panels featuring diverse industry perspectives on issues facing the E&L industry in both the US and globally. Learn More About This Event

Join The Mailing List 
to get the latest 2021 event updates!

Highlights From The 2020 Online Program:
  • The three day event included sessions that are crucial to the extractables and leachables industry, including the Global E&L Landscape, Safety Assessment Strategies, Analytical Challenges in E&L Profiling, The Role of Chemical Characterization in Establishing the Biocompatibility of Medical Devices, Regulatory Update, Analytical Advances, and Case Studies. VIEW THE 2020 AGENDA
  • The program included expert presentations from AstraZeneca, Safebridge Consultants, Jordi Labs, Becton Dickinson, the FDA, West Pharmaceutical Sciences, Baxter International, Amgen, Intertek, Smithers and many more. MEET THE 2020 SPEAKERS
  • Attendees joined in on a panel discussing the future direction of E&L, featuring Douglas Keihl, Research Advisor at Eli Lilly.
  • Thought Leadership Discussion: What is acceptable and achievable in terms of identification and quantitation?
  • Poster Session
  • The innovative online platform delivered the elements you know from our in-person events, and more, in a brand-new way. 

2021 Sponsors

View all 7 sponsors
Aspen Research
EKG Labs
Intertek
Leadscope
Shilpa Medicare
Smithers
Dennis Jenke - Triad Scientific Solutions, UK

Dennis Jenke

Chief Executive Scientist at Triad Scientific Solutions, UK
Dr. Cheryl Stults - C&M Technical Consulting

Dr. Cheryl Stults

Principal at C&M Technical Consulting
Carsten Worsøe - Novo Nordisk

Carsten Worsøe

Principal Scientist Extractables and Leachables at Novo Nordisk
Nick Morley - Hall Analytical Laboratories

Nick Morley

Principal Scientist at Hall Analytical Laboratories
Dr. Roger Pearson - Aspen Research Corporation

Dr. Roger Pearson

President of Analytical Services at Aspen Research Corporation
Paul Cummings - Smithers

Paul Cummings

General Manager E&L at Smithers
Dennis Jenke - Triad Scientific Solutions, UK

Dennis Jenke

Chief Executive Scientist at Triad Scientific Solutions, UK
Dr. Dujuan Lu - SGS

Dr. Dujuan Lu

Technical Client Manager/Global Lead - Life Science at SGS
Douglas J. Ball, MS, DABT - D&B ChemTox, LLC

Douglas J. Ball, MS, DABT

Managing Partner and Toxicology Consultant at D&B ChemTox, LLC
Benton Cartledge, Ph.D. - PPD Laboratories

Benton Cartledge, Ph.D.

Senior Scientist at PPD Laboratories
Mariah Ultramari, PhD - Spektra Consulting

Mariah Ultramari, PhD

Founder and Toxicologist Consultant at Spektra Consulting
Dr. Nikhil Sahotra - Markes International, UK

Dr. Nikhil Sahotra

Materials Emission Market Specialist at Markes International, UK

2020 Agenda

View Full Agenda
Session I: Global E&L Landscape
Session II: Safety Assessment Strategies
Session III: Analytical Challenges in E&L Profiling: Quantitation
Session IV: Analytical Challenges in E&L Profiling: Identification
Session V: The Role of Chemical Characterization in Establishing the Biocompatibility of Medical Devices
Session VI: Regulatory Update
Session VII: Analytical Advances
Session VIII: Case Studies
 
 

Learn About Smithers E&L Expertise

MEET OUR EXPERTS
e-l-smithers-expertise-3